🟢 Amgen is trading 3.11% up with no confirmed catalyst

Amgen is trading at $415.14, up 3.11% on October 7, 2026, with the reason for the intraday rise unconfirmed.

• Available search results showed no clear company-specific announcement or catalyst; Amgen’s investor press-release page had no October 7 release.
• The move came against a 2.50% biotech-sector decline and weaker major indexes, so neither sector nor broad-market direction clearly explains the gain.